跳至主要内容
临床试验/NCT07093281
NCT07093281尚未招募4 期

The Impact of Live Attenuated Intranasal Influenza Vaccine Exposure on Mucosal Immunity

University of Maryland, Baltimore2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2027年2月1日最近更新:
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
25
试验地点
2
主要终点
Serological outcomes will be compared before and after vaccination and between groups.

研究概览

简要总结

The research of the investigators is focused on the understanding how the immune system functions and responds to intranasal vaccines. Intranasal vaccines do not lead to the same changes in the blood that intramuscular vaccines do. Therefore, the investigators want to look at the function of immune (lymphoid) organs that are near the nose. The closest immune organs are the adenoids and tonsils. Mice do not have tonsils allowing for the investigators to answer these questions. Human lymphoid tissue will allow the investigators to better understand the molecular behavior of these cells in humans.

The purpose of this protocol is to administer the FDA approved live attenuated influenza vaccine or no vaccine to patients undergoing adenoidectomy and/or tonsillectomy for obstructive sleep apnea prior to surgery and then collect the tissue (adenoid and/or tonsil tissue) that would normally be discarded from surgery. This will allow for improved understanding of what happens after vaccination.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 89 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient undergoing tonsillectomy and adenoidectomy as part of the standard of care for sleep apnea

排除标准

  • Chronic Tonsillitis
  • Immune Deficiency
  • Already received this year's flu vaccine

研究组 & 干预措施

Interventional LAIV

Experimental

Intranasal Flu Vaccine

干预措施: Live Attenuated Influenza Vaccine (Biological)

No Intervention

No Intervention

No Intervention

结局指标

主要结局

Serological outcomes will be compared before and after vaccination and between groups.

时间窗: From enrollment to 4 weeks after surgery is completed

The comparisons will specifically compare: Mean HAI Ab titers in serum and mucosal secretions

次要结局

  • Influenza Specific Antibodies(From enrollment to 4 weeks after surgery)
  • Hemagglutinin Levels(From enrollment to 4 weeks after surgery)
  • Neuraminidase Levels(From enrollment to 4 weeks after surgery)
  • Seroconversion rats(From enrollment to 4 weeks post surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Adam Kaufman

Assistant Professor of Otolaryngology

University of Maryland, Baltimore

研究点 (2)

Loading locations...

相似试验

Intranasal LAIV Mucosal Immunity Examination | 临床试验